Amprion To Expand Diagnostic Testing For Neurodegenerative Disorders With Investment From Decathlon Capital Partners

Summary

Amprion has reached an agreement with Decathlon Capital Partners to expand diagnostic testing for neurodegenerative disorders. The investment provides flexible amortization without dilution or loss of management control for Amprion.